| Name | Title | Contact Details |
|---|
Zogenix is a global pharmaceutical company committed to developing and commercializing therapies with the potential to transform the lives of patients and their families living with rare diseases. The company has two late-stage development programs underway: FINTEPLA® (ZX008, fenfluramine oral solution) for the treatment of seizures associated with Dravet and Lennox-Gastaut syndromes, two rare and often-catastrophic childhood-onset epilepsies, and MT1621, a novel substrate enhancement therapy for the treatment of a rare genetic disorder called TK2 deficiency.
Quality Solutions is a Baltimore, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The mission of Mental Health Resources, Inc. is to foster hope, health and recovery for those affected by mental illness.
Inhaled nitric oxide has the potential to benefit patients, with a range of cardiopulmonary conditions including COVID-19 Coronavirus.
We provide mental health services and addiction treatment at our mental health facilities in the north Dallas, TX area. Contact us 24/7.